NCT00758498View on ClinicalTrials.gov

Study of the Effect of Armodafinil Treatment in Healthy Subjects With Excessive Sleepiness Associated With Jet Lag Disorder

PHASE3CompletedINTERVENTIONAL
Enrollment

427

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

February 28, 2009

Study Completion Date

February 28, 2009

Conditions
Excessive Sleepiness
Interventions
DRUG

armodafinil

50 mg/day orally, once daily in the morning for 3 days

DRUG

armodafinil

150 mg/day orally, once daily in the morning for 3 days

DRUG

placebo

placebo tablets, once daily in the morning for 3 days

Trial Locations (4)

10019

Clinilabs, Inc., New York

29201

SleepMed of South Carolina, Columbia

30342

Neurotrials Research, Inc., Atlanta

45217

Community Research, Crestview

Sponsors

Lead Sponsor

Cephalon
All Listed Sponsors
lead

Cephalon

INDUSTRY

NCT00758498 - Study of the Effect of Armodafinil Treatment in Healthy Subjects With Excessive Sleepiness Associated With Jet Lag Disorder | Biotech Hunter | Biotech Hunter